New research suggests that biological therapies (biologics) do not increase the risk of recurrent cancer compared to conventional disease modifying anti-rheumatic drugs (DMARDs). The study, which will be presented at Rheumatology 2014, analysed data from almost 19,000 patients with rheumatoid arthritis. The research examined the relationship between treatment type and new cancer cases in patients with rheumatoid arthritis who had previously had cancer. It compared patients taking biologics with those who had never taken these drugs.
More...
More...